Are you Dr. Graham?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 57 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
200 Hawkins Dr
Iowa City, IA 52242Phone+1 319-356-4302Fax+1 319-356-2220
Summary
- Dr. Michael Graham, MD is a board certified nuclear medicine physician in Iowa City, Iowa. He is currently licensed to practice medicine in Iowa and Washington. He is affiliated with University of Iowa Hospitals and Clinics and is a Professor at University of Iowa College of Medicine.
Education & Training
- University of WashingtonResidency, Nuclear Medicine, 1978 - 1980
- University of WashingtonResidency, Internal Medicine, 1976 - 1978
- University of California San Francisco School of MedicineClass of 1976
Certifications & Licensure
- IA State Medical License 1999 - 2025
- WA State Medical License 1977 - 2011
- American Board of Internal Medicine Internal Medicine
- American Board of Nuclear Medicine Nuclear Medicine
Clinical Trials
- Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's Lymphoma Start of enrollment: 2003 Sep 01
- FLT PET Imaging for Cervical Cancer Start of enrollment: 2009 Sep 01
- [F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers Start of enrollment: 2012 Oct 01
Publications & Presentations
PubMed
- 28 citationsLocalization of Unknown Primary Site with 68Ga-DOTATOC PET/CT in Patients with Metastatic Neuroendocrine Tumor.Yusuf Menda, Thomas M. O'Dorisio, James R. Howe, Michael K. Schultz, Joseph S. Dillon
Journal of Nuclear Medicine. 2017-02-02 - 9 citationsFibroblast Activation Protein Inhibitor-Based Radionuclide Therapies: Current Status and Future Directions.Manish Ora, Neetu Soni, Aftab Hasan Nazar, Manish Dixit, Rohit Singh
Journal of Nuclear Medicine. 2023-07-01 - 35 citationsSNMMI Procedure Standard/EANM Practice Guideline for SSTR PET: Imaging Neuroendocrine Tumors.Thomas A Hope, Martin Allen-Auerbach, Lisa Bodei, Jeremie Calais, Magnus Dahlbom
Journal of Nuclear Medicine. 2023-02-01
Grant Support
- Quantitative Imaging To Assess Response In Cancer Therapy TrialsNational Cancer Institute2010–2012
- To Develop A PLAN For Molecular Imaging Comparative Effectiveness ResearchAgency For Healthcare Research And Quality2010
- Tumor ImagingNational Cancer Institute2005–2009
- Molecular Imaging Of Responses To Cancer TherapyNational Cancer Institute2001–2003
- Early Assessment Of Therapeutic Response In LymphomasNational Cancer Institute2001–2002
- Core--BiostatisticsNational Cancer Institute2001–2002
- Metabolic Imaging Of Cancer (Core C Analysis)National Center For Research Resources1996–2002
- FDG PET Imaging Of Colon Carcinoma Response To TherapyNational Cancer Institute2000–2001
- Glucose &Fdg Imaging In CancerNational Center For Research Resources1999
- FDG PET Imaging Of Colon Carcinoma Response To TherapyNational Cancer Institute1997–1999
- Core--Imaging CoreNational Heart, Lung, And Blood Institute1996–1998
- Metabolic Imaging Of Cancer (Core C: Analysis)National Center For Research Resources1997
- Impact Of Noise And Heterogeneity On Parameter EstimationNational Cancer Institute1996–1997
- Core--Positron Emission Tomography Imaging And Data AnalysisNational Cancer Institute1996–1997
- Metabolic Imaging And Its Response To TherapyNational Cancer Institute1992–1996
- Child &Adolescent Service System ProgramNational Institute Of Mental Health1989
- Modification Of Radiation-Induced Vascular PermeabilityNational Cancer Institute1987–1989